Effects of Lactobacillus salivarius-containing tablets on caries risk factors: a randomized open-label clinical trial
- 2014-09-02
- RCT · n = 72
- BMC Oral Health 14(1)
- Tetsuyo Nishihara
- N. Suzuki
- M. Yoneda
- T. Hirofuji
- PubMed: 25178882
- DOI: 10.1186/1472-6831-14-110
- High evidence
- Rigorous Journal
The salivary buffering capacity significantly increased in the L. salivarius TI 2711 group (P = 0.003) and Ovalgen® DC group (P = 0.002) compared to the xylitol group.
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes